NCT05372276 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Filgueiras A, Hall CR
Psychometric properties of the Brazilian-adapted version of Sport Imagery Questionnaire. Psicol Reflex Crit. 2017 Oct 4;30(1):22. doi: 10.1186/s41155-017-0075-7.
Gucciardi DF, Hanton S, Fleming S
Are mental toughness and mental health contradictory concepts in elite sport? A narrative review of theory and evidence. J Sci Med Sport. 2017 Mar;20(3):307-311. doi: 10.1016/j.jsams.2016.08.006. Epub 2016 Aug 9.
Papathanasiou G, Georgoudis G, Georgakopoulos D, Katsouras C, Kalfakakou V, Evangelou A
Criterion-related validity of the short International Physical Activity Questionnaire against exercise capacity in young adults. Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):380-6. doi: 10.1097/HJR.0b013e328333ede6.

A Comparison of Mental Toughness and Mental Imagination Skills of Professional Esports Players With Different Levels of Physical Activity

Clinical trial NCT05372276 - References